Related Experiment Videos
Ferro-mitogens: iron-containing compounds with lymphocyte-stimulatory properties
A Novogrodsky1, M Suthanthiran, K H Stenzel
1Rogosin Institute, Cornell University Medical Center, New York, New York.
Cellular Immunology
|April 1, 1991
Summary
Ferric ammonium citrate (FAC) acts as a T-cell mitogen with Interleukin-2 (IL-2), stimulating human peripheral blood mononuclear cells (PBM). This effect, potentiated by IL-2, involves iron-containing compounds and suggests a role for oxygen radicals.
Area of Science:
- Immunology
- Cell Biology
Background:
- Ferric ammonium citrate (FAC) is typically nonmitogenic for human peripheral blood mononuclear cells (PBM).
- Interleukin-2 (IL-2) is crucial for T-cell proliferation and function.
Purpose of the Study:
- To investigate the mitogenic potential of Ferric ammonium citrate (FAC) in combination with IL-2.
- To explore the role of macrophages and signaling pathways in FAC-induced PBM stimulation.
Main Methods:
- Culturing human peripheral blood mononuclear cells (PBM) with FAC and IL-2.
- Assessing cell proliferation and receptor expression (IL-2, transferrin).
- Investigating the effects of Concanavalin A (Con A) and inhibitors like thiourea and 3-amino-1,2,4-triazole.
Main Results:
- FAC with IL-2 significantly increases PBM proliferation and expression of IL-2 and transferrin receptors.
- FAC acts as a T-cell mitogen requiring macrophages and potentiates IL-2-induced TNF-alpha and IFN-gamma production.
- Inhibitors suggest oxygen radicals or peroxidase mediate FAC-induced mitogenesis.
Conclusions:
- Ferric ammonium citrate (FAC) is a potent ferro-mitogen for human PBM when combined with IL-2.
- The mitogenic activity involves macrophage-dependent T-cell activation and cytokine production.
- Oxygen radicals likely play a role in the signaling pathway of this ferro-mitogen class.